1Goldhaber SZ. Contemporary pulmonary embolism thrombolysis.Chest, 1995 ,107(1 Suppl):45S-51S. 被引量：1
2Hyers TM, Agnelli G, Hull RD, et al.Antithrombotic therapy for venous thromboembolic disease.Chest, 2001,119(1 Suppl):176S-193S. 被引量：1
3Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology.Eur Heart J,2000,21:1301-1336. 被引量：1
4Konstantinides S, Geibel A, Olschewski M, et al.Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry.Circulation,1997,96:882-888. 被引量：1
5Daniels LB, Parker JA, Patel SR, et al.Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.Am J Cardiol,1997,80:184-188. 被引量：1
6Verstraete M, Miller GA, Bounameaux H, et al.Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.Circulation,1988,77:353-360. 被引量：1
7Benotti JR,Dalen JE.The natural history of pulmonarg embolism.Clinics in Chest Medicine,1984,5(3):405 被引量：1
8Oger E,Leroger C,Le Moigne,et al.The value of a risk analysis in clinically suspected deep venous thrombosis.Respiration,1997,6(4):326-330 被引量：1
